Virus Diseases Completed Phase 2 / 3 Trials for Telbivudine (DB01265)

Also known as: Virus Disease

IndicationStatusPhase
DBCOND0028162 (Virus Diseases)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02447705Replacement of Lamivudine by Telbivudine to Improve Renal FunctionTreatment